Lexaria Bioscience Corp. (LEXX)
0.5502
-0.01
(-1.77%)
USD |
NASDAQ |
May 19, 09:34
Lexaria Bioscience Free Cash Flow : -9.470M for Feb. 28, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CannaPharmaRx, Inc. | -0.7891M |
| InMed Pharmaceuticals, Inc. | -7.710M |
| Target Group, Inc. (Canada) | -0.4808M |
| Tilray Brands, Inc. | -75.96M |
| NervGen Pharma Corp. | -17.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.164M |
| Cash from Investing (Quarterly) | -0.0539M |
| Cash from Financing (Quarterly) | 3.044M |
| Free Cash Flow Per Share (Quarterly) | -0.0908 |
| Free Cash Flow to Equity (Quarterly) | -2.212M |
| Free Cash Flow to Firm (Quarterly) | -2.220M |
| Free Cash Flow Yield | -82.27% |